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Abstract 1 
 2 
Background and Objectives: Patient Blood Management (PBM) in Europe is a working group of the 3 
European Blood Alliance with the initial objective to identify the starting position of the participating 4 
hospitals regarding PBM for benchmarking purposes, and to derive good practices in PBM from the 5 
experience and expertise in the participating teams with the further aim of implementing and 6 
strengthening these practices in the participating hospitals.  7 
Methods: We conducted two surveys in seven university hospitals in Europe:  Survey on top indications for 8 
red cell use regarding usage of red blood cells during one week and Survey on PBM organisation and 9 
activities. 10 
Results: 3,320 units of red blood cells were transfused in one week at the seven hospitals. Overall, 61% of 11 
red cell units were transfused to medical patients and 36% to surgical patients, although there was much 12 
variation between hospitals. The organisation and activities of PBM in the seven hospitals were variable, 13 
but there was a common focus on optimising the treatment of bleeding patients, monitoring the use of 14 
blood components and treatment of pre-operative anaemia.  15 
Conclusion: Although the seven hospitals provide a similar range of clinical services, there was variation in 16 
transfusion rates between them. Further, there was variable implementation of PBM activities and 17 
monitoring of transfusion practice. These findings provide a baseline to develop joint action plans to further 18 
implement and strengthen PBM across a number of hospitals in Europe. 19 
Introduction 20 
Patient Blood Management (PBM) is an evidence-based, multidisciplinary approach to optimise the care of 21 
patients who might need blood transfusion. The objective of PBM is to improve patient outcomes and to 22 
reduce unnecessary transfusion. The PBM approach consists of three main pillars: To optimise the 23 
haemoglobin concentration, to minimise blood loss and to optimise the patient’s tolerance of anaemia[1]. 24 
The scientific basis for PBM has been described[2], and the evidence for the importance of treating 25 
preoperative anaemia[3] and for restrictive transfusion practices[4-7] is increasing. 26 
Patient Blood Management in Europe (PaBloE) is a working group of the European Blood Alliance (EBA) 27 
which is an association of not-for-profit blood establishments (http://www.europeanbloodalliance.eu/). 28 
PaBloE was established in 2014 by bringing together specialists with an interest in PBM from seven 29 
university hospitals in Europe and associated blood service representatives. Its objectives were to derive 30 
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good practices in PBM based on the experience and expertise of the participating PaBloE teams, and to 1 
develop ways to implement and strengthen these practices in the participating hospitals.  2 
In order to develop such action plans the first step was to obtain an understanding of existing practice, for 3 
example which groups of patients are using most blood components and the variation in blood component 4 
use between hospitals, to identify where it will be most rational to look for improvement in the future. 5 
Furthermore, a key issue was to obtain information about how PBM is organised in different hospitals, and 6 
what the constraints are to further implementation of PBM. This will provide useful baseline information 7 
about PBM and a foundation to create tools to implement PBM across a range of hospitals throughout 8 
Europe. 9 
To obtain this information, and to be able to initiate the benchmarking processes, we launched two 10 
surveys:  Survey on top indications for red cell use and Survey on PBM  organisation and activities. 11 
Methods 12 
Members of PaBloE were selected because of their interest in PBM and their willingness to participate in 13 
the collaboration. Seven hospitals associated with the PaBloE team members were approached to answer 14 
the surveys and all participated; no hospitals outside PaBloE were invited. 15 
In the Survey of top indications for red cell use[S1], we collected data on all red cell transfusions issued to 16 
the  seven participating hospitals from Monday 12th May 2014 to Sunday 18th May 2014, inclusive. Data 17 
from every transfusion episode were collected using a one page pre-printed form to report the age and 18 
gender of the patients, the number of units transfused and the clinical indication for the transfusion. 19 
Subsequently the data were entered on-line, and submitted to NHS Blood & Transplant National 20 
Comparative Audit team for analysis. The report form was originally developed for surveys of hospitals in 21 
the North of England, carried out on three occasions from 1999 to 2009[8], and used again across the 22 
whole of England in early 2014[9]. The indication for transfusion was categorised into either: Surgical 23 
indications, gynaecological/obstetric indications or medical indications. In six locations, the indication for 24 
transfusion was collected manually by a medical doctor, and at one location the indication was based on 25 
the ward where the patient was admitted.  26 
In the Survey on PBM organisation and activities[S2], data were collected about the participating hospitals 27 
including the number of beds and surgical procedures and which clinical services were provided. 28 
Furthermore, data were collected on the number of surgical and medical patients transfused with red cells 29 
(according to location of patient) and the number of blood components transfused. The survey also 30 
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included information about how PBM was organised, what PBM activities were conducted, which PBM 1 
initiatives were successful, what activities will be prioritised in the future and what the constraints are for 2 
further implementation of PBM. The survey was developed based on a survey delivered to English hospitals 3 
in 2013[10], with some additional questions added by the PaBloE working group. It was launched in January 4 
2015 on Survey Monkey (www.surveymonkey.com). The answers regarding number of beds, surgical 5 
procedures, transfused patients and blood components correspond to the calendar year of 2013. Answers 6 
regarding PBM organisation and activities were collected in January 2015. The ratios of the transfused 7 
blood components, red cell:plasma, red cell:platelet and plasma:platelet were calculated from the units of 8 
the different blood components, even though we are aware that the content of some of the units vary from 9 
hospital to hospital. 10 
Results 11 
The characteristics of the seven participating university hospitals are shown in Table 1. The following 12 
services were provided in all seven hospitals: Cardiac, ear, nose and throat (ENT) and gastrointestinal 13 
surgery, haematology including haematopoietic transplants and haemoglobinopathy, oncology, organ 14 
transplantation, trauma, orthopaedic, urological and vascular surgery. Obstetrics, paediatrics and 15 
maxillofacial surgery were provided by six of the seven hospitals. The number of inpatient beds ranged 16 
from 953 to 3000. The number of surgical interventions ranged from 18,935 to 114,307 per year. 17 
 18 
Results of the “2014 Survey of Top Indications for Red cell Use” 19 
The results from this survey are based on transfusion of 3,320 units of red cells in the seven hospitals (Table 20 
1). 59% of the red cell units were transfused to men, and the mean age of the patients was 60 years. 61% of 21 
red cell units were transfused for medical indications, 36% for surgical indications and 3% for 22 
gynaecological or obstetric indications. The proportion of units for medical indications ranged from 45% in 23 
Frankfurt to 77% in Mater Dei Hospital, Malta. The top medical indication was haematological disease, 24 
followed by gastrointestinal bleeding and critical care (Table 2). Almost half of the medical indications for 25 
red cell transfusion and one third of the total indications were haematological. The proportion of 26 
haematological red cell  transfusions relative to the total red cell  transfusions was high at all hospitals and 27 
varied from 21% in Odense University Hospital, Denmark, to 43% in Central Manchester University 28 
Hospitals, UK. The top surgical indications were cardiothoracic, followed by gastrointestinal and trauma 29 
(Table 2). 30 
6 
 
Results of the “Survey on PBM organisation and activities” 1 
Blood component consumption 2 
The numbers of blood components transfused in the participating hospitals are shown in Table 1, and the 3 
relative use of the three blood components is shown as ratios in Table 3. All of the calculated ratios (red 4 
cell:plasma, red cell:platelet and plasma:platelet) varied by more than two fold across the seven  hospitals, 5 
and the largest variation was found in the red cell:platelet ratio which ranged between 2.5 in University 6 
Hospital Frankfurt, Germany to 10.4 in Mater Dei Hospital, Malta. Another noteworthy difference was the 7 
plasma:platelet ratio; at Karolinska, almost twice as many plasma units were transfused as platelets, while 8 
in Manchester twice as many platelets were transfused as plasma units. 9 
There were also large differences between hospitals in the proportion of red cell units transfused per 10 
number of inpatient beds (Table 4). Mater Dei transfused 4.8 red cells per inpatient bed while Karolinska 11 
transfused 31.3 red cells per inpatient bed. One reason for the low rate of transfusions in Mater Dei 12 
hospital is that a large proportion of the beds are for elderly patients in rehabilitation, and Karolinska has 13 
highly specialized care. 14 
Figure 1 shows the number of medical and surgical patients who received red cell transfusions. At three 15 
hospitals more medical than surgical patients were transfused, at one hospital almost an equal number of 16 
medical and surgical patients were transfused and at one hospital more surgical than medical patients were 17 
transfused; the Frankfurt group only reported number of surgical patients in this survey. The total numbers 18 
of transfused medical and surgical patients, in the five hospitals that reported both number of surgical and 19 
medical patients, were almost equal (10,727 surgical patients vs. 10,914 medical patients). This is in 20 
contrast to the results of our red cell survey in May 2014 and the survey in England, where almost two 21 
thirds of the red cells went to medical patients, and a possible conclusion is that transfused medical 22 
patients receive more red cell units than transfused surgical patients although these data were not 23 
collected in this survey. The differences might also be an outcome of two different ways of allocating the 24 
patients to the medical or surgical speciality. In the Survey on PBM organisation and activities, patients 25 
were divided by location, and in the Survey of top indications for red cell use they were divided by 26 
indication for transfusion; the latter is likely to provide a more accurate reflection of the reason for 27 
transfusion. 28 
The number of transfused surgical patients in relation to number of surgical interventions appeared to vary 29 
hugely between the participating hospitals although no correction was applied to correct for the relative 30 
proportions of major and minor surgery undertaken at each hospital (Table 4). 31 
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Results of the “Survey on PBM organisation and activities” 1 
PBM Activities 2 
Six out of the seven participating hospitals indicated they were implementing PBM in January 2015, and 3 
those six hospitals had all facilitated PBM activities that included “safe transfusion practice”, and 4 
“appropriate use of blood components”. These six hospitals had a hospital transfusion committee, meaning 5 
a group or committee responsible for overseeing transfusion practice in the hospital with the objective to 6 
promote best practice through local based protocols based on guidelines, and to promote education and 7 
training of all clinical and support staff involved in blood transfusion. Five of the committees had 8 
implemented PBM initiatives. Three of the hospitals had staff with time allocated for PBM activities. Two 9 
hospitals maintained a database that allowed feedback on performance to all hospital staff involved in 10 
blood transfusion. Only Frankfurt evaluated the cost efficiency of PBM. 11 
The PBM training at the hospitals was delivered by PBM experts, transfusion practitioners or hospital blood 12 
bank staff. In one location training was provided by an e-learning module with an incorporated multiple 13 
choice test. Transfusion training for medical doctors was provided in five of the seven hospitals. In less than 14 
half of the hospitals, transfusion training took place within the first month that the medical doctors were 15 
allowed to prescribe blood components. 16 
Three hospitals used electronic blood ordering while three other hospitals were progressing electronic 17 
ordering. At two of the hospitals with electronic ordering and at three of the hospitals with paper 18 
requesting, the indication for transfusion was included as a field when the components were requested. 19 
This field was mandatory at three of the hospitals, and the request was not processed without the 20 
information provided. 21 
Three out of the seven hospitals undertook audits of blood component transfusion according to their local 22 
policies. In five of the seven hospitals, the cost of the blood components was allocated to the clinical 23 
specialty. Only three of the hospitals had a system for reporting blood component usage to individual 24 
clinicians or clinical teams. 25 
In the survey we also asked for standard procedures regarding patient consent and patient information, 26 
and following replies were given: Only very few patients received information about risks, benefits and 27 
alternatives to blood transfusion. This information was part of routine practice at only one of the seven 28 
hospitals. Very few patients were given an information leaflet, and documentation of a valid consent was 29 
rarely found in the clinical records of patients who might need transfusion (less than 10% in the majority of 30 
hospitals). 31 
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All of the hospitals provided a range of PBM activities with all providing at least half of the activities listed in 1 
Table 5, but none providing all of the activities. Table 6 gives an overview of recent PBM initiatives in the 2 
participating hospitals, which were diverse and cover all aspects of PBM. The PBM initiatives prioritised by 3 
the hospitals for implementation in the future are also shown in Table 6 indicating a common desire for 4 
better pre-operative treatment of anaemia and more monitoring and auditing of blood usage with 5 
benchmarking of blood usage for clinical teams. 6 
Finally, the participating hospitals were asked to give examples of the local constraints for the successful 7 
implementation of the PBM initiatives prioritised for implementation. Common features were lack of 8 
training and a hospital culture not supportive of PBM. Other constraints were poor pre-operative patient 9 
flow, poor engagement with PBM from medical professionals and hospital managers, and lack of funding, 10 
staff and information technology support. 11 
Discussion 12 
Our survey, which followed the fate of red cell units issued in one week in the seven hospitals, found that 13 
61% of red cell transfusions went to patients for medical indications which corresponds with the findings of 14 
the surveys from the North and the whole of England[8, 9]. Data were also similar for the proportion of red 15 
cell transfusions administered to patients with haematological diseases (30% in our survey).  This high 16 
proportion of transfusions to haematological patients was a general feature seen at all of the hospitals, 17 
which makes haematological patients an obvious target for PBM in the future, and specifically the 18 
appropriate use of transfusion according to local or national guidelines. 19 
Large differences in the relative use of the three blood components were found between the seven 20 
hospitals, and the ratios between the three blood components varied considerably. There was also large 21 
variation in the proportion of red cell units used per inpatient bed and the proportion of surgical patients 22 
transfused per surgical intervention. We know that blood consumption varies considerably between 23 
European countries. In European Directorate for the Quality of Medicines report from 2012 the number of 24 
red cell  units per 1,000 inhabitants varies from 27 in the Netherlands to 58 in Germany[11]. However, the 25 
variations we found in our survey could also be due to limitations of our study.  The definition of “inpatient 26 
beds” and “surgical procedures” and definitions of what a medical or a surgical patient is might vary from 27 
hospital to hospital, since strict definitions were not provided when the surveys were sent to the hospitals. 28 
Other factors may also contribute to these large differences such as variations between hospitals in the 29 
allocation of patients to the diagnostic categories used in the survey, differences between hospitals in 30 
medical and surgical management, and differences between countries in guidelines for transfusion, 31 
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availability of blood components and the volume and/or composition of blood components. For example 1 
the content in the plasma units in Torino varies from 200 ml to 500 ml, but at the other six hospitals the 2 
average volume of plasma units is between 271 ml and 312 ml. Similarly, the dose of platelets in a unit 3 
varies from >200 x 109 to >300 x 109. In conclusion, the limitations mentioned above make it difficult to 4 
make robust comparisons in blood transfusion rates between the hospitals participating in this study. The 5 
results from the surveys might not reflect the status of European hospitals in general, since the surveys 6 
were conducted at university hospitals with a connection to PaBloE team members who have a special 7 
interest in PBM, and six out of the seven hospitals have active PBM programmes.  8 
The implementation of PBM in January 2015 in the seven university hospitals included in this study was 9 
variable, which corresponds with the findings of previous studies[1]. Possible reasons for the variable 10 
implementation of PBM are differences in the knowledge of and interest in PBM, despite the fact that PBM 11 
is becoming more prevalent in Europe and indeed worldwide, and the principles of PBM are evidence 12 
based and widely accepted[2]. Variable support from clinicians and hospital managers, and inadequate 13 
financial resources, staff and information technology almost certainly contributed to this variation. Since 14 
some of the variability we find is probably due to differences between the counties, it could be interesting 15 
to compare the variability we find, with the variability found within one country. Further studies are 16 
needed to assess these differences and their significance in the successful implementation of PBM. 17 
In conclusion, seven university hospitals across Europe providing a similar range of clinical services were 18 
found to have considerable differences in blood usage and transfusion practice. Some of the differences 19 
may be due to limitations in the methodology of data collection and also due to a variation in clinical 20 
casemix in the hospitals. However, they may also be due to the observed variable implementation of PBM 21 
measures found in this study.  22 
Further understanding of the reasons for the commonalities and differences in transfusion practice and 23 
PBM implementation between these seven university hospitals in Europe provides the opportunity to share 24 
experiences and develop new strategies and joint action plans about how best to implement PBM, not only 25 
in the seven participating hospitals but in hospitals across Europe using the lessons learned in this project. 26 
Guided by the results of these two initial surveys, further work by the PaBloE group will focus on the 27 
development of implementation strategies for the management of pre-operative anaemia and clinical 28 
studies to better understand transfusion strategies in patients with haematological disorders. 29 
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Charcteristics of 
the hospitals:  
n  n n n n n n 
Beds in 2013 1,286 1,6 1,42 3 1,126 1,225 953 
Surgical inter-
ventions in 2013 
25 51,916 77,724 47,274 18,935 114,307 45,495 
Transfusions in one 
week, May 2014: 
n(%)  n(%)  n(%)  n(%)  n(%)  n(%)  n(%)  
Red cell units to 
medical indications 
210(45) 531(61) 344(76) 224(77) 292(60) 278(56) 150(58) 
Red cell units to 
surgical indications 
257(55) 313(36) 85(19) 43(15) 196(40) 207(42) 98(38) 
Red cell units to 
gyn/obs indications 
1(0) 24(3) 21(5) 23(8) - 12(2) 11(4) 
Total red cell units 
transfused  
468 
(100) 
868 
(100) 
450 
(100) 
290 
(100) 
488 
(100) 
497 
(100) 
259 
(100) 
Transfusions in 
2013 
n n n n n n n 
Red blood cells 21,363 50,089 21,174 14,274 24,549 29,561 12,109 
Platelet units 8,432 8,075 5,971 1,376 5,735 5,224 4,398 
Plasma units 7,972 13,587 2,735 2,231 5,91 6,368 2,764 
 3 
 4 
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 Table 2:  1 
Top medical indications Top surgical indications 
Haematological  30.0% Cardiothoracic  9.8% 
Gastro-intestinal bleeding  7.0% Gastrointestinal  5.7% 
Critical Care  4.4% Trauma  3.9% 
Cancer non-haematological 4.2% Orthopaedics  3.5% 
Neonatal  3.0% Vascular  3.0% 
 2 
  3 
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Table 3:  1 
Hospital Red cell:Plasma ratio Red cell:Platelet ratio Plasma:Platelet ratio 
Radboud University Medical Centre, 
Nijmegen, The Netherlands 
4.4 2.8 0.6 
University Hospital Frankfurt, 
Germany 
2.7 2.5 0.9 
Central Manchester University 
Hospitals NHS Foundation Trust, UK 
7.7 3.5 0.5 
Molinette University Hospital, Torino, 
Italy 
4.2 4.3 1.0 
Mater Dei Hospital, Msida, Malta 6.4 10.4 1.6 
Odense University Hospital, Denmark 4.6 5.7 1.2 
Karolinska, Stockholm, Sweden 3.7 6.2 1.7 
       
 2 
  3 
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Figure 1:  1 
2 
 *Data not provided by Karolinska. The Frankfurt group only reported number of surgical patients  3 
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Table 4:  1 
 2 
Hospital 
Number of  red cell 
transfusions/number of beds 
Proportion of transfused surgical 
patients/number of surgical 
interventions 
Radboud University Medical Centre, 
Nijmegen, The Netherlands 
12.7 2.7% 
University Hospital Frankfurt, 
Germany 
16.6 8.6% 
Central Manchester University 
Hospitals NHS Foundation Trust, UK 
14.9 2.5% 
Molinette University Hospital, Torino, 
Italy 
21.8 11.8% 
Mater Dei Hospital, Msida, Malta 4.8 2.4% 
Odense University Hospital, Denmark 24.1 3.5% 
Karolinska, Stockholm, Sweden 31.3 Data not provided 
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Table 5:  1 
PBM activities provided 
Fr
an
kf
u
rt
 
K
ar
o
lin
sk
a 
M
an
ch
es
te
r 
 
M
al
ta
 
To
ri
n
o
 
O
d
en
se
 
R
ad
b
o
u
d
  
Comments 
Policy to identify and correct anaemia 
before considering transfusion 
X   X X     X 
3 in medical patients, 
2 preoperative 
Access to i.v. ion X X X X   X X   
Policy to reduce phlebotomy X         X   Not all specialities 
Protocol for management of 
anticoagulant patients bleeding or 
requering surgery 
X X X X   X X 
Including bleeding 
patients on novel 
anticoagulants 
Protocol for management of abnormal 
haemostasis in patients with major 
haemorrhage 
X X X X   X X   
Use of tromboelastography to guide 
therapy in patients with haemorrhage     
X X X X X     
Use varies by 
indication 
Use of anti-fibrinolytics (e.g. Tranexamic 
Acid) for major bleeding 
X X X X X X X 
Use varies by 
indication 
Use of intraoperative cell salvage (IOCS) X X X X X X X 
Use varies by 
indication 
Use of pre-operative autologous blood 
donation (PABD)  
X X     X       
Use of locally agreed triggers for 
transfusion based on national or local 
guidelines 
X X X X X X X 
6 based on national 
guidelines 
Policy for transfusing one unit at a time in 
non-bleeding patients 
  X X   X X X 2 RBC/5 platelets 
Protocols that empower transfusion 
laboratory staff to question and challenge 
requests 
    X X X       
 2 
 3 
 4 
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Table 6:  1 
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, S
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 M
an
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U
n
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ty
 H
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s 
N
H
S 
Fo
u
n
d
at
io
n
 T
ru
st
 
M
at
e
r 
D
ei
 H
o
sp
it
al
, 
M
al
ta
 
M
o
li
n
et
te
 U
n
iv
er
si
ty
 
H
o
sp
it
al
, T
o
ri
n
o
, I
ta
ly
 
O
d
en
se
 U
n
iv
er
si
ty
 
H
o
sp
it
al
, D
en
m
ar
k 
R
ad
b
o
u
d
 U
n
iv
er
si
ty
 
M
ed
ic
al
 C
e
n
tr
e,
 
N
ij
m
eg
en
/ 
Th
e 
N
e
th
er
la
n
d
s 
R
e
ce
n
t 
P
B
M
 in
it
ia
ti
ve
s 
Introduced 
anemia walk-
in-clinic for 
elective 
patients ahead 
of surgery 
ROTEM 
targeted 
therapy in 
trauma, 
cardiac 
surgery, liver 
surgery 
Big data 
project linking 
transfusion 
and lab data 
to patient data 
MSBOS 
(Maximal 
Surgical Blood 
ordering 
Schedule) 
N/A N/A 
Implementing 
Type and 
Screen 
procedure 
Ideas' 
competition 
among 
students 
Close 
collaboration 
between 
transfusion 
medicine 
specialists and 
clinicians  
Algorithm for 
requesting 
platelets in 
cardiac 
surgery based 
on TEG and 
platelet 
mapping  
Auditing of 
blood 
component 
use 
N/A N/A 
Promoting a 
policy for 
transfusing 
one unit of red 
cells at a time 
in stable 
patients 
Reduced size 
of blood 
collecting 
tubes 
PhD students 
in different 
blood 
transfusion 
projects  
Pilot study of 
management 
of pre op 
anaemia in 
cardiac 
surgery 
Intraoperative 
cell salvage 
N/A N/A 
Starting pilot 
of ROTEM 
based 
transfusion 
policy in post 
operative 
patients 
P
ri
o
ri
ti
e
s 
fo
r 
P
B
M
 
Further 
bloodless 
surgery 
Employ a 
nurse 
dedicated for 
PBM and 
transfusion 
safety 
Hospital wide 
anaemia 
management 
service 
Database for 
capturing of 
information 
Evaluation and 
treatment of 
pre operative 
anaemia 
Implement 
new evidence 
based national 
guidelines 
Implementing 
ROTEM for 
bleeding 
patients 
Improve 
preoperative 
patient flow 
Improved 
statistics of 
blood usage 
and feedback 
to clinicians 
Dashboard to 
monitor key 
performance 
indicators for 
PBM 
More frequent 
auditing 
Single RBC unit 
policy 
Optimise the 
treatment of 
bleeding 
patients.. 
Audit and 
feedback on 
performance 
Treat non-
iron-
deficiency-
anemia 
Evaluation and 
treatment of 
pre operative 
anaemia 
Single RBC unit 
policy 
Recruitment 
of additional 
FTE (full-time 
equivalents) 
for PBM 
Reduction of 
sample blood 
volume for 
blood tests 
Evaluation and 
treatment of 
pre operative 
anaemia 
Promoting 
iron therapy in 
case of iron 
deficiency 
anemia 
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